Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Classifica tra le azioni #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Prezzo delle azioni
$1.11
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$10.06M
Variazione (1 giorno)
1.38%
Variazione (1 anno)
-55.98%
Paese
US
Scambia Lisata Therapeutics, Inc. (LSTA)

Categoria

Cronologia dei frazionamenti azionari per Lisata Therapeutics, Inc. (LSTA)
L’azione Lisata Therapeutics, Inc. (simbolo: LSTA) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 18, 2026.
Una quota di LSTA acquistata prima di Aug 18, 2026 equivale oggi a 0 quote di LSTA.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE